{"ok":true,"trend":{"id":615512,"platform":"news","region":"global","key":"microdosing glp-1s, explained: what it is, why it's trending, and what an obesity medicine doctor wants patients to know","title":"Microdosing GLP-1s, explained: what it is, why it's trending, and what an obesity medicine doctor wants patients to know","url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNcThJcmRqbnRsZmUwSktKeHZUZ3ZWdzdyY2JoaklhN2lwTkNOYVh3cWtnODRFMmFZSlJxV2xIRThOOEt4Wm5iUGdndlpOTngxSGhMcVVOSHZrZmJhVEtSQmxld2p3TUYzcVNMbnM4QlZRQTJwMUlEZ1hkWTc2Yi1zdjhvWjVReVYteEV5SU1nclJMVHJmN19zRFdBTFRzOG1MZldZNzFWbEpSclJiSk1KYmVGTnFoRG43MEozRXUtc0lqNzg4LU1XeURlRHY2dnRxQi1lTUY4OUpwa3VteE9ybEkzV1JXMjVFeDhrQmJpcW4zdFNmWnRtZG5COE1tSWVrMkdZ?oc=5","first_seen":"2026-10-01T13:51:19.770102Z","last_seen":"2026-10-01T13:51:19.770102Z","last_rank":33,"peak_rank":33,"last_volume":null,"peak_volume":null,"seen_count":1,"score":0.628125,"category_hint":"medicine","section":"health","category":"medicine","summary":"Some patients taking GLP-1 weight-loss drugs such as Ozempic and Wegovy are experimenting with microdosing, using lower doses than prescribed, often to cut costs or reduce side effects. An obesity medicine doctor is explaining what the practice involves and urging caution, since evidence for smaller-than-approved doses is limited and self-adjusting medication without medical supervision carries risks.","why":"GLP-1 drugs are hugely popular and rising costs and side effects are driving interest in taking smaller doses.","tone":"neutral","entities":["GLP-1 drugs","Ozempic","Wegovy","obesity medicine doctors"],"summarized_at":"2026-10-01T13:53:33.140699Z","meta":{"via":"scan","lang":"en","term":"medicine","source":"Yahoo Creators","published":"Thu, 01 Oct 2026 12:06:49 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"Microdosing GLP-1s: what patients should know","section_name":"Health","category_name":"Medicine","timeline":[{"captured_at":"2026-10-01T13:51:19.770102Z","rank":33,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNcThJcmRqbnRsZmUwSktKeHZUZ3ZWdzdyY2JoaklhN2lwTkNOYVh3cWtnODRFMmFZSlJxV2xIRThOOEt4Wm5iUGdndlpOTngxSGhMcVVOSHZrZmJhVEtSQmxld2p3TUYzcVNMbnM4QlZRQTJwMUlEZ1hkWTc2Yi1zdjhvWjVReVYteEV5SU1nclJMVHJmN19zRFdBTFRzOG1MZldZNzFWbEpSclJiSk1KYmVGTnFoRG43MEozRXUtc0lqNzg4LU1XeURlRHY2dnRxQi1lTUY4OUpwa3VteE9ybEkzV1JXMjVFeDhrQmJpcW4zdFNmWnRtZG5COE1tSWVrMkdZ?oc=5","author":"Yahoo Creators","title":"Microdosing GLP-1s, explained: what it is, why it's trending, and what an obesity medicine doctor wants patients to know","snippet":null,"posted_at":"2026-10-01T12:06:49Z","likes":null}],"elsewhere":[],"window":"7d"}}